Name | NEZAVISIMAYA LABORATORIYA INVITRO, OOO |
|---|
INN | 7710294238 |
|---|
KPP | 773001001 |
|---|
OGRN | 1037739468381 |
|---|
OKPO | 49898343 |
|---|
Address | 121059, G.MOSKVA, ul. Kievskaya, d. 7, pomesch. 1 |
|---|
Phone | Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 86.90.9 | Core activity | Other independent activities in health care | | 46.46.2 | Additional activity | Wholesale of medical and orthopedic goods, dental and laboratory supplies | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | All types of activities | | 70.22 | Additional activity | Advice on business and management | | 71.20.1 | Additional activity | Technical testing and analysis | | 72.19 | Additional activity | Research and experimental development on natural sciences and engineering Other | | 72.20 | Additional activity | Research and development in the field of social sciences and humanities | | 73.11 | Additional activity | Activities of advertising agencies | | 75.00 | Additional activity | veterinary activities | | 77.39.26 | Additional activity | Rental and leasing of equipment, vehicles and other equipment used for medical purposes | | 86.10 | Additional activity | Hospitals | | 86.21 | Additional activity | General practice |
Registration date | 06.02.2003 |
|---|
Registering department | Gosudarstvennoe uchrezhdenie Moskovskaya registratsionnaya palata |
|---|
|
INVITRO, OOO (Moscow; INN 7710294238) was registered on 6 Feb 2003. The company's authorized capital as of July 1, 2012 was 31410000 rub. Type of ownership of INVITRO, OOO - Limited liability companies. Form of ownership of INVITRO, OOO - Property of foreign legal entities. Principal activities of INVITRO, OOO: other independent activities in health care (86.90.9), wholesale of medical and orthopedic goods, dental and laboratory supplies (46.46.2), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74). |
Economic indicators2024
Net profit (RAS) of INVITRO, OOO grew over 2024 4.23 times to 1.48 billion RUB from 349.71 million RUB over 2023, the company informed. Revenue increased in the accounting period by 21.75% to 14.32 billion RUB from 11.76 billion RUB over 2023; cost of goods sold grew by 14.96% to 8.78 billion RUB from 7.64 billion RUB; sales profit went up 2.03 times to 2.11 billion RUB from 1.04 billion RUB. 2023
Net profit (RAS) of INVITRO, OOO dropped in 2023 2.01 times to 349.71 million RUB from 703.73 million RUB over the same period in 2022, the company informed. Revenue increased in the accounting period by 4.46% to 11.76 billion RUB from 11.26 billion RUB over 2022; cost of goods sold grew by 5.60% to 7.64 billion RUB from 7.23 billion RUB; sales profit went up by 29.24% to 1.04 billion RUB from 802.93 million RUB. 2022
Net profit (RAS) of INVITRO, OOO dropped in 2022 2.91 times to 703.73 million RUB from 2.05 billion RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 19.23% to 11.26 billion RUB from 13.94 billion RUB in 2021; cost of goods sold decreased by 9.39% to 7.23 billion RUB from 7.98 billion RUB; sales profit fell 2.60 times to 802.93 million RUB from 2.08 billion RUB. 2021
Net profit (RAS) of INVITRO, OOO grew over 2021 1.91 times to 2.05 billion RUB from 1.07 billion RUB over 2020, the company informed. Revenue increased in the accounting period by 36.81% to 13.94 billion RUB from 10.19 billion RUB over 2020; cost of goods sold grew by 33.59% to 7.98 billion RUB from 5.98 billion RUB; sales profit went up by 47.67% to 2.08 billion RUB from 1.41 billion RUB. 2020
Net profit (RAS) of INVITRO, OOO grew over 2020 61.13 times to 1.07 billion RUB from 17.55 million RUB over 2019, the company informed. Revenue increased in the accounting period by 3.73% to 10.19 billion RUB from 9.82 billion RUB over 2019; cost of goods sold grew by 8.36% to 5.98 billion RUB from 5.52 billion RUB; sales profit went up by 41.13% to 1.41 billion RUB from 999.82 million RUB. 2019
Net profit (RAS) of INVITRO, OOO dropped in 2019 10.05 times to 17.55 million RUB from 176.45 million RUB over the same period in 2018, the company informed. Revenue decreased in the accounting period by 10.66% to 9.82 billion RUB from 11.00 billion RUB in 2018; cost of goods sold grew by 5.06% to 5.52 billion RUB from 5.25 billion RUB; sales profit fell by 14.64% to 999.82 million RUB from 1.17 billion RUB. 2018
Net profit (RAS) of INVITRO, OOO dropped in 2018 2.18 times to 176.45 million RUB from 384.94 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 12.45% to 11.00 billion RUB from 9.78 billion RUB over 2017; cost of goods sold grew by 14.34% to 8.22 billion RUB from 7.19 billion RUB; sales profit went up by 2.21% to 1.17 billion RUB from 1.15 billion RUB. 2017
Net profit (RAS) of INVITRO, OOO grew over 2017 by 21.61% to 1.02 billion RUB from 836.24 million RUB over 2016, the company informed. Revenue increased in the accounting period by 10.11% to 9.78 billion RUB from 8.88 billion RUB over 2016; cost of goods sold grew by 7.76% to 7.19 billion RUB from 6.67 billion RUB; sales profit went up by 18.93% to 1.15 billion RUB from 963.53 million RUB. 2016
Net profit (RAS) of INVITRO, OOO dropped in 2016 by 17.84% to 836.24 million RUB from 1.02 billion RUB over the same period in 2015, the company informed. Revenue increased in the accounting period by 10.49% to 8.88 billion RUB from 8.04 billion RUB over 2015; cost of goods sold grew by 13.13% to 6.67 billion RUB from 5.90 billion RUB; sales profit fell by 7.22% to 963.53 million RUB from 1.04 billion RUB. 2014
Net profit (RAS) of INVITRO, OOO grew over 2014 by 31.51% to 995.39 million RUB from 756.87 million RUB over 2013, the company informed. Revenue increased in the accounting period by 21.97% to 6.65 billion RUB from 5.45 billion RUB over 2013; cost of goods sold grew by 30.51% to 4.52 billion RUB from 3.46 billion RUB; sales profit went up by 9.37% to 864.84 million RUB from 790.77 million RUB. 2013
Net profit (RAS) of INVITRO, OOO grew over 2013 by 45.92% to 756.87 million RUB from 518.67 million RUB over 2012, the company informed. Revenue increased in the accounting period by 28.88% to 5.45 billion RUB from 4.23 billion RUB over 2012; cost of goods sold grew by 26.35% to 3.46 billion RUB from 2.74 billion RUB; sales profit went up by 46.62% to 790.77 million RUB from 539.34 million RUB. 2012
Net profit (RAS) of INVITRO, OOO grew over 2012 2.19 times to 518.67 million RUB from 236.41 million RUB over 2011, the company informed. Revenue increased in the accounting period by 30.51% to 4.23 billion RUB from 3.24 billion RUB over 2011; cost of goods sold grew by 32.46% to 2.74 billion RUB from 2.07 billion RUB; sales profit went up by 46.05% to 539.34 million RUB from 369.28 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|